Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-14-000059
Filing Date
2014-07-01
Accepted
2014-07-01 20:19:46
Documents
1
Period of Report
2014-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3421
  Complete submission text file 0000874015-14-000059.txt   4718
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
PARSHALL B LYNNE (Reporting) CIK: 0001073385 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 14954098